Silica nanoparticles for improving efficiency of virus-like particle based hepatitis B vaccine
Închide
Articolul precedent
Articolul urmator
570 0
SM ISO690:2012
ROMANOVA, Marina, DEKHTYAR, Yuri, KACHANOVSKA, Anna, SKRASTINA, Dace, RENHOFA, Regina, PUMPENS, Paul, PATMALNIEKS, Aloizijs. Silica nanoparticles for improving efficiency of virus-like particle based hepatitis B vaccine. In: Nanotechnologies and Biomedical Engineering, Ed. 1, 7-8 iulie 2011, Chișinău. Technical University of Moldova, 2011, Editia 1, pp. 344-346. ISBN 978-9975-66-239-0..
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Nanotechnologies and Biomedical Engineering
Editia 1, 2011
Conferința "International Conference on Nanotechnologies and Biomedical Engineering"
1, Chișinău, Moldova, 7-8 iulie 2011

Silica nanoparticles for improving efficiency of virus-like particle based hepatitis B vaccine


Pag. 344-346

Romanova Marina1, Dekhtyar Yuri1, Kachanovska Anna1, Skrastina Dace2, Renhofa Regina2, Pumpens Paul2, Patmalnieks Aloizijs3
 
1 Biomedical Engineering and Nanotechnologies Institute, Riga Technical University,
2 Latvian Biomedical Research and Study centre,
3 University of Latvia
 
 
Disponibil în IBN: 25 iulie 2019


Rezumat

Adherence of hepatitis B virus-like particles (VLP) to silica (SiO2) nanoparticles was explored for immunomodulation purposes. Optical absorbance measurements, transmission electron microscopy and fluorescence microscopy were employed to study the adherence. The results demonstrated that hepatitis B VLP + SiO2 complexes were formed. Preliminary immunological experiments with vaccination of Balb/c mice with the VLP only and VLP + SiO2 complexes were performed. The vaccination with VLP + SiO2 complexes resulted in increase in antibody production in mice blood. The amount of antibodies produced strongly depended on the concentration of SiO2 nanoparticles. The observed results suggest that SiO2 nanoparticles can be considered as a promising material for improving efficiency of VLP-based vaccines against hepatitis B viral disease.

Cuvinte-cheie
hepatitis B, optical absorbance, silica nanoparticles, vaccines, virus-like particles